
|Articles|November 1, 2001
Low-dose STS minimizes risks while eradicating small veins
Dallas - Low-dose sodium tetradecyl sulfate (STS, Sotradecol) is highly effective for sclerotherapy of small veins on the lower extremities but has the benefit of an enhanced safety profile relative to higher concentrations, Robert A. Weiss, M.D., said at the annual meeting of the American Society for Dermatologic Surgery.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
Top 5 Articles of the Week: December 7-12
4
Transformative Advances This Year and Beyond
5


















